The U.S. Centers for Disease Control and Prevention is reeling from a tumultuous year — a battered agency that endured chaotic layoffs and has been injected with misinformation under the leadership of Secretary of Health and Human Services Robert F. Kennedy Jr. — an anti-vaccine activist.
While much of the global health impacts under the Trump administration came in the wake of the dismantling of the U.S. Agency for International Development, and many changes to CDC have been domestic — there’s still a raft of changes impacting the Atlanta-based agency’s ability to effectively execute its global health work.
This worries both current and former staff who’ve invested deeply in building the foundation for this work.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Sara Jervingsarajerving
Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.
